Clinical Trials Logo

Clinical Trial Summary

From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate state changes in regional brain function, along with a better understanding of the neural networks affected by depression and SD. Here we propose to study a group of N=48 antidepressant-free male and female patients with current depression symptom and N=12 healthy controls with no history of mood disorders before and after SD to provide mechanistic insight into the neural substrates underlying the antidepressant effects of SD. We hypothesize that SD-induced concurrent functional activity and connectivity changes in multiple brain networks related to different depressive symptom dimensions including emotion regulation, attention, arousal, self-referential, and reward processing will underlie the rapid and transient antidepressant effects of SD. Using an ABA design, multimodal brain imaging along with more traditional electroencephalographic (EEG) and neurobehavioral testing data will be acquired at baseline after normal sleep, during one night of total SD, and after one night of recovery sleep using a 5-day in laboratory protocol during which subjects will be continuously monitored by trained staff.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03169543
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase N/A
Start date April 1, 2016
Completion date February 28, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05114824 - Acceptability and Feasibility of an 8-week Online Mindfulness-Based Cognitive Therapy Program Among Undergraduate Students N/A
Not yet recruiting NCT05958940 - BioClock: Bright Light Therapy for Depressive Disorders N/A
Completed NCT03556735 - Pulsed Electro Magnetic Fields (PEMF) in Depression N/A
Completed NCT04916548 - Repeated Neurocognitive Measurements in Depressed Patients Phase 1/Phase 2
Recruiting NCT05767073 - LIVES: Personalized Lifestyle Intervention for Patients With Depression N/A
Completed NCT06094907 - Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression Phase 2
Completed NCT04121091 - Pramipexole to Target "Anhedonic Depression" Phase 2
Recruiting NCT06092411 - Effects of CBT and BLT in Youth With Unipolar Depression and Evening Chronotype N/A
Enrolling by invitation NCT03847688 - Machine Learning to Predict Clinical Response to TMS
Completed NCT02945735 - Gaze Contingent Feedback in Major Depressive Disorder (MDD) N/A
Recruiting NCT06139159 - CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos N/A
Recruiting NCT05011864 - Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression N/A
Terminated NCT03537547 - Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder Phase 4
Completed NCT03515733 - PF-04995274 and Emotional Processing in Treatment Resistant Depression Phase 1
Not yet recruiting NCT05991232 - Repeated Neurocognitive Measurements in Depressed Patients Phase 1/Phase 2
Completed NCT03516604 - PF-04995274 and Emotional Processing in Un-medicated Depression Phase 1
Completed NCT03538275 - Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
Active, not recruiting NCT03096886 - Novel Neural Circuit Biomarkers of Major Depression Response to CCBT N/A
Not yet recruiting NCT06462196 - Natural History of Depression, Bipolar Disorder and Suicide Risk
Completed NCT01874951 - Low-Dose Naltrexone for Depression Relapse and Recurrence Phase 2